Florida Cancer Care — Davie, Florida

Florida Cancer Care is a clinical research site located in Davie, Florida, United States 33328.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Florida Cancer Care has participated in 3 clinical trials.

Therapeutic areas: Metastatic Breast Cancer, Breast Cancer.

Sponsors: Genentech, Inc., Eisai Inc., SCRI Development Innovations, LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Davie

Browse all research sites in Florida · View every site in Davie

• Nova South Eastern university
• Nova Southeastern University
• Nova Southeastern University, David and Cathy Husman Neuroscience Institute
• Nova Southeastern University HPD Annex Building
• Nova Southeastern University College of Nursing
• Florida Cancer Research Institute
• Research Site
• Alfa Medical Research
• Pfizer Investigational Site
• Heart Rhythm Solutions
• Florida Cancer Research Institute Dept of Oncology

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Florida Cancer Care?

Florida Cancer Care has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Florida Cancer Care conducted?

Florida Cancer Care has 3 clinical trials on record. Their work covers Metastatic Breast Cancer, Breast Cancer.

Is Florida Cancer Care accredited by Crixeo Clinical Trials?

Florida Cancer Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Florida Cancer Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.